Efinaconazole is a synthetic triazole antifungal agent indicated for the topical treatment of onychomycosis, a fungal infection of the nail. As a 14α-demethylase inhibitor, it functions by blocking the… Read more





![Chemical structure of (2R,3R)-2-(2,4-Difluorophenyl)-3-(1-oxa-6-azaspiro[2.5]octan-6-yl)-1-(1H-1,2,4-triazol-1-yl)butan-2-ol](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F2R3R-2-24-Difluorophenyl-3-1-oxa-6-azaspiro2.5octan-6-yl-1-1H-124-triazol-1-ylbutan-2-ol.png&w=3840&q=75)

![Chemical structure of (2R,3R)-2-(2,4-Difluorophenyl)-3-methyl-2-[(1H-1,2,4-triazol-1-yl)methyl]oxirane](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F135270-13-2-2R3R-2-24-Difluorophenyl-3-methyl-2-1H-124-triazol-1-ylmethyloxirane.png&w=3840&q=75)



![Chemical structure of (2R,3R)-3-((1H-1,2,4-Triazol-1-yl)methyl)-6-fluoro-3-hydroxy-2-methyl-4'-methylenespiro[indoline-1,1'-piperidin]-1-ium Fluoride](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F2252350-11-9-2R3R-3-1H-124-Triazol-1-ylmethyl-6-fluoro-3-hydroxy-2-methyl-4-methylenespiroindoline-11-piperidin-1-ium-Fluoride.png&w=3840&q=75)








![Chemical structure of (2S,3R)-2-(2,4-Difluorophenyl)-3-methyl-2-[(1H-1,2,4-triazol-1-yl)methyl]oxirane](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F135270-07-4-2S3R-2-24-Difluorophenyl-3-methyl-2-1H-124-triazol-1-ylmethyloxirane.png&w=3840&q=75)



![Chemical structure of (2S,3S)-2-(2,4-Difluorophenyl)-3-methyl-2-[(1H-1,2,4-triazol-1-yl)methyl]oxirane](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F135270-10-9-2S3S-2-24-Difluorophenyl-3-methyl-2-1H-124-triazol-1-ylmethyloxirane.png&w=3840&q=75)








![Chemical structure of 1-((R)-1-((R)-8-((1H-1,2,4-Triazol-1-yl)methyl)-4-fluoro-7-oxabicyclo[4.2.0]octa-1(6),2,4-trien-8-yl)ethyl)-4-methylenepiperidine](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F1-R-1-R-8-1H-124-Triazol-1-ylmethyl-4-fluoro-7-oxabicyclo4.2.0octa-1624-trien-8-ylethyl-4-methylenepiperidine.png&w=3840&q=75)












Efinaconazole is a synthetic triazole antifungal agent indicated for the topical treatment of onychomycosis, a fungal infection of the nail. As a 14α-demethylase inhibitor, it functions by blocking the biosynthesis of ergosterol, an essential component of fungal cell membranes, which leads to fungal cell death. This category provides comprehensive reference standards for Efinaconazole and its associated compounds, including process-related impurities, degradation products, stereoisomeric variants, and metabolites. These reference standards are critical in pharmaceutical laboratories for impurity profiling, method validation, and stability testing, ensuring the safety and quality of the drug under regulatory guidelines. Furthermore, stable isotope labelled compounds are available to serve as high-precision internal standards for analytical techniques such as LC-MS, facilitating accurate identification and quantification in complex matrices. These materials support the entire drug development lifecycle, from early research and method development to routine quality control.